- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05226611
The Effect of Counterstrain Technique on Muscle Stiffness and Pain on Trapezius Tender Points in Medical Students
January 25, 2022 updated by: New York Institute of Technology
Medical students are prone to developing neck pain due to prolonged studying and poor posture.
This can manifest as tender points in the upper trapezius region.
Counterstrain (CS) is an osteopathic manipulative technique that has shown efficacy in previous studies in treating tender points.
The MyotonPRO is a myotonometric device that can be used to measure various muscle parameters such as muscle stiffness.
There is limited research regarding the use of osteopathic manipulative medicine to produce measurable changes in muscle stiffness by the MyotonPRO.
This educational study aims to establish the efficacy of CS technique in decreasing the pain level of upper trapezius tender points in medical students as well as determining if CS causes a significant decrease in muscle stiffness in treated tender points as measured by the MyotonPRO.
The investigators hope this educational study will encourage further studies on how osteopathic manipulative techniques affects the physiologic parameters of muscles.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
27
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Glen Head, New York, United States, 11545
- NYIT College of Osteopathic Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subject is at least 18 years of age
Exclusion Criteria:
- Traumatized (sprained or strained) tissues, which would be negatively affected by the positioning of the patient
- Illness or other conditions in which strict positional restrictions preclude treatment
- Instability of the area being positioned that has the potential to produce unwanted neurologic or vascular side effects
- Vascular or neurologic syndromes, such as basilar insufficiency or neural foraminal compromise whereby the position of treatment has the potential to exacerbate the condition
- Severe degenerative spondylosis with local fusion and no motion at the level where treatment positioning would normally take place
- Pregnancy
- Positive for COVID-19 as well as symptoms indicating a SARS-CoV-2 infection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Tender point treatment with Counterstrain
A tender point was located in the upper trapezius region of the test subject and treated with counterstrain.
The side with the highest initial pain level was used as the treatment side.
Pain level was measured before and after treatment.
The MyotonPRO was also used to measure physiologic parameters of the muscle before and after treatment.
|
Counterstrain is a hands-on OMM technique that involves shortening the muscle to resolve the dysfunctional muscle stretch reflex and holding it for 90 seconds.
The patient is then brought back to a neutral position and reassessed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain level
Time Frame: This was done immediately before and immediately after counterstrain treatment. Counterstrain treatment is a hands-on osteopathic manipulative technique that involves shortening the muscle belly of the painful region.
|
Pain level of the tender point as rated by the test subject out of a scale of 1 to 10, 1 being very little pain and 10 being the most pain the test subject has ever felt.
|
This was done immediately before and immediately after counterstrain treatment. Counterstrain treatment is a hands-on osteopathic manipulative technique that involves shortening the muscle belly of the painful region.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Muscle Stiffness
Time Frame: This was done immediately before and immediately after counterstrain treatment. Counterstrain treatment is a hands-on osteopathic manipulative technique that involves shortening the muscle belly of the painful region.
|
Muscle stiffness measured by the MyotonPRO, a myotonometric device that applies a brief mechanical impulse to the targeted muscle, used to measure physiologic parameters such as muscle stiffness.
|
This was done immediately before and immediately after counterstrain treatment. Counterstrain treatment is a hands-on osteopathic manipulative technique that involves shortening the muscle belly of the painful region.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 10, 2021
Primary Completion (Actual)
April 14, 2021
Study Completion (Actual)
April 14, 2021
Study Registration Dates
First Submitted
January 12, 2022
First Submitted That Met QC Criteria
January 25, 2022
First Posted (Actual)
February 7, 2022
Study Record Updates
Last Update Posted (Actual)
February 7, 2022
Last Update Submitted That Met QC Criteria
January 25, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- #BHS-1561
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.